MedPath

Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma

Recruiting
Conditions
ESCC
Radiomics
Lymph Node Metastasis
Registration Number
NCT07050576
Lead Sponsor
The First Affiliated Hospital of Anhui Medical University
Brief Summary

This study aims to develop a predictive model using deep learning and radiomics to assess the likelihood of lymph node metastasis in patients with early-stage esophageal squamous cell carcinoma (ESCC). Lymph node metastasis is a critical factor in determining the treatment approach and prognosis for ESCC patients. By analyzing medical imaging data, we hope to create a non-invasive method that can assist doctors in making more accurate treatment decisions. This research could improve patient outcomes by enabling earlier and more tailored interventions.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Patients with pathologically confirmed early-stage (T1) ESCC
  • Preoperative contrast-enhanced CT data within 2 weeks before surgery
  • Without any treatment before surgical resection
Exclusion Criteria
  • Patients who underwent neoadjuvant therapy or endoscopic treatment
  • Insufficient CT imaging or poor CT quality
  • Incomplete pathology results
  • Presence of metastatic disease

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
AUC(the area under the curve) values of the model4 years

The performance and clinical relevance of the models were assessed by analyzing the area under the curve (AUC).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The First Affiliated Hospital of Anhui Medical University

🇨🇳

Hefei, Anhui, China

The First Affiliated Hospital of Anhui Medical University
🇨🇳Hefei, Anhui, China
Hao Zheng, MD
Contact
+86 139 1793 6873
pojunayfy@gmail.com
© Copyright 2025. All Rights Reserved by MedPath